Nyumbani › Limfoma ya Folikuli
Majaribio ya kliniki ya Limfoma ya Folikuli yanayovutia washiriki nchini Marekani
Masomo 107 ya Limfoma ya Folikuli yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- New York City, NYUtafiti 24
- Milwaukee, WIUtafiti 19
- Nashville, TNUtafiti 18
- Houston, TXUtafiti 18
- Boston, MAUtafiti 17
- Baldwin Park, CAUtafiti 16
- Seattle, WAUtafiti 15
- Durham, NCUtafiti 15
- Columbus, OHUtafiti 13
- Salt Lake City, UTUtafiti 13
- Chicago, ILUtafiti 12
- Philadelphia, PAUtafiti 12
- San Antonio, TXUtafiti 12
- Dallas, TXUtafiti 11
- Denver, COUtafiti 11
- Los Angeles, CAUtafiti 11
- Atlanta, GAUtafiti 11
- Washington, DCUtafiti 11
- Edison, NJUtafiti 11
- Rochester, MNUtafiti 10
- Jacksonville, FLUtafiti 10
- Portland, ORUtafiti 9
- Cleveland, OHUtafiti 9
- Cincinnati, OHUtafiti 9
- New Haven, CTUtafiti 9
- Pittsburgh, PAUtafiti 8
- Miami, FLUtafiti 8
- San Diego, CAUtafiti 8
- San Francisco, CAUtafiti 8
- Tampa, FLUtafiti 7
- Charlotte, NCUtafiti 7
- Clifton, NJUtafiti 7
- St. Louis, MOUtafiti 7
- Mountain View, CAUtafiti 7
- Queens, NYUtafiti 7
- Cedar Rapids, IAUtafiti 7
- Austin, TXUtafiti 6
- Greenburgh, NYUtafiti 6
- Winston-Salem, NCUtafiti 6
- Buffalo, NYUtafiti 5
Kwa jimbo
- AlabamaUtafiti 5
- ArizonaUtafiti 11
- ArkansasUtafiti 3
- CaliforniaUtafiti 36
- ColoradoUtafiti 14
- ConnecticutUtafiti 10
- DelawareUtafiti 4
- FloridaUtafiti 25
- GeorgiaUtafiti 15
- IllinoisUtafiti 14
- IndianaUtafiti 7
- IowaUtafiti 9
- KansasUtafiti 7
- KentuckyUtafiti 10
- LouisianaUtafiti 8
- MarylandUtafiti 9
- MassachusettsUtafiti 20
- MichiganUtafiti 12
- MinnesotaUtafiti 18
- MississippiUtafiti 4
- MissouriUtafiti 9
- NebraskaUtafiti 4
- New JerseyUtafiti 15
- New MexicoUtafiti 3
- New YorkUtafiti 30
- North CarolinaUtafiti 23
- OhioUtafiti 23
- OklahomaUtafiti 4
- OregonUtafiti 11
- PennsylvaniaUtafiti 17
- Rhode IslandUtafiti 4
- South CarolinaUtafiti 6
- TennesseeUtafiti 19
- TexasUtafiti 35
- UtahUtafiti 13
- VirginiaUtafiti 9
- WashingtonUtafiti 19
- Wilaya ya ColumbiaUtafiti 4
- WisconsinUtafiti 21
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT03460977Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
InaajiriHatua 3
Umri 12 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07215910Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
InaajiriUtafiti wa uchunguzi
Umri 0 hadi 38 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT061318015HTP Regulation Of Asthma In Children
InaajiriHatua 2
Umri 8 hadi 18 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT04160910Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07631598A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05006716Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06350318A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
InaajiriHatua 2/3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07634471A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07519772Epco, Zanu, Ritux for R/R FL or MZL
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06563596Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT06784167A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07226843Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT06453044A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
InaajiriHatua 3
Umri 18 hadi 130 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06549595huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07343934NEO100 and High-Grade Meningioma
InaajiriHatua 2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT05023018Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
InaajiriHatua 3
Umri 12 hadi 100 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06091254Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT07225439A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06043323A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
InaajiriUtafiti wa uchunguzi
Umri 0 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT07154823Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.